a year ago they had high hopes of commercializing the life science division. Still not one commercial deal. I'll be sending a question in asking what hurdles they are facing in getting customers to commit to a deal. We have years of data. It works. It works incredibly well. What's stopping these life science, particles manufacturers, vaccine companies from signing?
from the outside, it looks like the life science division is dead
or maybe we need a bit more mongrel in the management team
Ann: Half Yearly Results Timing & Investor Update Call, page-4
-
- There are more pages in this discussion • 117 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
